Author Archive: AZBio

Governor Ducey Announces Enhanced COVID-19 Action Plan

Posted on by

Governor Ducey, Dr. Christ, Maj. Gen McGuire provided an Arizona COVID-19 briefing on June 17, 2020. Governor Ducey reminded everyone of Three Key Messages for all Arizonans:

  1. You are safest at home.
  2. If you must go out, physically distance.
  3. If you can not, Wear A Mask.

Executive Order 40 includes that  “4.  Notwithstanding directives in Executive Order 2020-36, Stay Healthy, Return Smarter, Return Stronger, regarding A.R.S. § 26-307, a county, city or town may, based on conditions in its jurisdiction, adopt policies regarding the wearing of face coverings in public for the purpose of mitigating the spread of COVID-19. Any enforcement of such a policy shall focus first on educating and working to promote best practices to accomplish the goal of mitigation. An individual shall be notified of the provisions of this order or any policy adopted by a county, city or town and given an opportunity to comply prior to any enforcement action being taken.”

Continue reading→

Mask Up Arizona

Posted on by

Wearing a mask when in a public setting, staying a safe distance away from other people, and following CDC recommendations relative disinfecting and personal hygiene can help slow the spread of COVID-19. This is key to improving health and to our economic recovery. 

Joan Koerber-Walker, president & CEO, AZBio  #MaskUpAZ #MaskUpArizona

Continue reading→

New Report Examines Bioscience Industry’s Economic Impact in Arizona & Role in Global Pandemic

Posted on by

Chandler, Arizona – The Biotechnology Innovation Organization (BIO) released new data on the bioscience industry in the United States. The new report, The Bioscience Economy: Propelling Life-Saving Treatments, Supporting State & Local Communities, analyzes the bioscience industry’s economic footprint across the nation and in Arizona, the significant role of small- and mid-sized companies, and the industry’s response to the COVID-19 pandemic.Continue reading→

RCT Acquires Translational Drug Development, LLC

Posted on by

Tucson, Ariz. & Scottsdale, Ariz. / June 4, 2020
Research Corporation Technologies, Inc. (RCT) announced today that it has acquired and invested growth capital into Translational Drug Development (TD2), the leading fully integrated precision oncology medicine development organization.
TD2 provides end-to-end solutions, including translational preclinical services; regulatory strategic guidance, planning and document submission services; and clinical trial design and execution for innovative oncology-focused companies.Continue reading→